American Society of Metabolic and Bariatric Surgery review of gut microbiome and...

Abstract The gut microbiome is a critical mediator of metabolic health including obesity and type 2 diabetes (T2D). Microbial composition...

Obesity Medicine Pharmacology for the Metabolic and Bariatric Surgery Patient

Target Audience: Advanced Practice Providers (APPs) Registration is now open in the ASMBS Learning Management System. Enroll today. This Assessment Based Certificate is...

American Society for Metabolic and Bariatric Surgery review of endobariatric procedures

Abstract Background Endoscopic bariatrics is a growing area of interest in the battle against obesity. This systematic review provides a...

American Society for Metabolic and Bariatric Surgery Systematic Review of Literature Surrounding...

Abstract Patients seeking metabolic and bariatric surgery (MBS) are treated by an interdisciplinary team of surgeons and integrated health professionals...

Integrated Health Fellow of the American Society for Metabolic & Bariatric Surgery

FASMBS INTEGRATED HEALTH SECTION DESIGNATION PROGRAM We are happy to announce that the American Society for Metabolic & Bariatric Surgery...

Bariatric Happy Hour! Mastering the Maze: Insurance Approvals, Denials, and Prior Authorizations...

Recorded August 28, 2025

The FELLOW Project: The History of Bariatric Surgery

Recorded Aug. 1, 2025

Dr. Richard M. Peterson Elected 39th President of American Society for Metabolic...

CONTACT: ASMBS@compartnersny.com Newberry, FL – July 9, 2025 – Richard M. Peterson, MD, MPH, FACS, FASMBS, DABS-FPMBS, Professor and Chief of...

Bariatric Surgery vs. GLP-1 Medications: What the Latest Research Shows

New Study Highlights Superiority of Bariatric Surgery Over GLP-1 Medications for Sustained Weight Loss A new real-world study presented at...

Head-to-head Study Shows Bariatric Surgery Superior to GLP-1 Drugs for Weight Loss

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists...